Citadel Advisors’s Dermata Therapeutics DRMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-117
Closed -$7.03K 6093
2024
Q1
$7.03K Buy
+117
New +$7.03K ﹤0.01% 5720
2023
Q3
Sell
-115
Closed -$28.5K 5992
2023
Q2
$28.5K Buy
+115
New +$28.5K ﹤0.01% 5162
2022
Q3
Sell
-33
Closed -$52K 6050
2022
Q2
$52K Buy
+33
New +$52K ﹤0.01% 5490